CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-15 | Hata Yujiro S President and CEO | Option exercise · Stock Option (right to buy) | −47,564 | 494,055 | ||
| 2020-03-30 | Stone Paul A. Chief Financial Officer | Option exercise | +5,000 | $4.62 | $23K | 15,000 |
| 2020-03-30 | Stone Paul A. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,000 | 140,932 | ||
| 2020-02-21 | Stone Paul A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-02-21 | Hata Yujiro S President and CEO | Grant or award · Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2020-02-21 | Lackner Mark SVP, Head of Biology | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-02-21 | Dillon Michael P. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2020-02-21 | Hambleton Julie SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-12-17 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-10-09 | Throne Jason VP, General Counsel | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-09-24 | ROSEN TERRY J Director | Grant or award · Stock Option (right to buy) | +1,250 | 1,250 | ||
| 2019-09-24 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +1,250 | 1,250 | ||
| 2019-09-24 | DIEKMAN JOHN D Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2019-09-24 | Stein Jeffrey Director | Grant or award · Stock Option (right to buy) | +1,250 | 1,250 | ||
| 2019-09-24 | SHANNON TIMOTHY M Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2019-07-30 | Hata Yujiro S President and CEO | Option exercise | +15,000 | $4.31 | $65K | 610,722 |
| 2019-07-30 | Hata Yujiro S President and CEO | Option exercise · Stock Option (right to buy) | −15,000 | 541,619 | ||
| 2019-07-26 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise | +5,197 | $4.31 | $22K | 127,853 |
| 2019-07-26 | Hager Jeffrey SVP, Chief Technology Officer | Option exercise · Stock Option (right to buy) | −5,197 | 10,396 | ||
| 2019-07-26 | Stone Paul A. SVP, General Counsel | Option exercise | +10,000 | $4.62 | $46K | 10,000 |
Page 16 of 19 · 370 trades